NZ508392A - Multiparticulate delayed release pharmaceutical form comprising at least two independent polymers with different permeability rates - Google Patents
Multiparticulate delayed release pharmaceutical form comprising at least two independent polymers with different permeability ratesInfo
- Publication number
- NZ508392A NZ508392A NZ508392A NZ50839299A NZ508392A NZ 508392 A NZ508392 A NZ 508392A NZ 508392 A NZ508392 A NZ 508392A NZ 50839299 A NZ50839299 A NZ 50839299A NZ 508392 A NZ508392 A NZ 508392A
- Authority
- NZ
- New Zealand
- Prior art keywords
- coating
- polymer
- active material
- composition
- multiparticulate
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 4
- 230000003111 delayed effect Effects 0.000 title abstract 2
- 230000035699 permeability Effects 0.000 title abstract 2
- 239000011248 coating agent Substances 0.000 abstract 7
- 238000000576 coating method Methods 0.000 abstract 7
- 239000011149 active material Substances 0.000 abstract 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920003176 water-insoluble polymer Polymers 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008119 colloidal silica Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 229940075507 glyceryl monostearate Drugs 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9806384A FR2778848B1 (fr) | 1998-05-20 | 1998-05-20 | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
| PCT/FR1999/001201 WO1999059557A1 (fr) | 1998-05-20 | 1999-05-20 | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ508392A true NZ508392A (en) | 2002-09-27 |
Family
ID=9526556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ508392A NZ508392A (en) | 1998-05-20 | 1999-05-20 | Multiparticulate delayed release pharmaceutical form comprising at least two independent polymers with different permeability rates |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1077687B1 (enExample) |
| JP (1) | JP2002515423A (enExample) |
| KR (1) | KR100583065B1 (enExample) |
| CN (1) | CN1186014C (enExample) |
| AT (1) | ATE214598T1 (enExample) |
| AU (1) | AU758299B2 (enExample) |
| BG (1) | BG64764B1 (enExample) |
| BR (1) | BR9910606A (enExample) |
| CA (1) | CA2333188C (enExample) |
| DE (1) | DE69901062T2 (enExample) |
| DK (1) | DK1077687T3 (enExample) |
| ES (1) | ES2173739T3 (enExample) |
| FR (1) | FR2778848B1 (enExample) |
| GE (1) | GEP20022750B (enExample) |
| HU (1) | HU224193B1 (enExample) |
| IL (1) | IL139774A (enExample) |
| MX (1) | MXPA00011364A (enExample) |
| NO (1) | NO330501B1 (enExample) |
| NZ (1) | NZ508392A (enExample) |
| PL (1) | PL192950B1 (enExample) |
| PT (1) | PT1077687E (enExample) |
| TR (1) | TR200100107T2 (enExample) |
| WO (1) | WO1999059557A1 (enExample) |
| ZA (1) | ZA200006768B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| EP1802285B1 (en) | 2004-10-21 | 2013-02-27 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| AU2013273835B2 (en) * | 2005-05-02 | 2016-07-07 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| WO2008136016A1 (en) * | 2007-05-08 | 2008-11-13 | Medreich Limited | A stable controlled release oral solid dosage form composition and a process thereof |
| JP5309262B2 (ja) | 2009-12-02 | 2013-10-09 | アプタリス ファーマ リミテッド | フェキソフェナジン・マイクロカプセル及びそれを含む組成物 |
| FR2999432B1 (fr) | 2012-12-17 | 2014-12-12 | Ethypharm Sa | Comprimes orodispersibles obtenus par compression moulage |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
| US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
| FR2754710B1 (fr) * | 1996-10-22 | 1998-12-31 | Prographarm Lab | Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle |
-
1998
- 1998-05-20 FR FR9806384A patent/FR2778848B1/fr not_active Expired - Lifetime
-
1999
- 1999-05-20 GE GEAP19995632A patent/GEP20022750B/en unknown
- 1999-05-20 NZ NZ508392A patent/NZ508392A/xx not_active IP Right Cessation
- 1999-05-20 JP JP2000549222A patent/JP2002515423A/ja active Pending
- 1999-05-20 CA CA2333188A patent/CA2333188C/fr not_active Expired - Lifetime
- 1999-05-20 DE DE69901062T patent/DE69901062T2/de not_active Expired - Lifetime
- 1999-05-20 ES ES99920897T patent/ES2173739T3/es not_active Expired - Lifetime
- 1999-05-20 DK DK99920897T patent/DK1077687T3/da active
- 1999-05-20 KR KR1020007013020A patent/KR100583065B1/ko not_active Expired - Fee Related
- 1999-05-20 MX MXPA00011364A patent/MXPA00011364A/es active IP Right Grant
- 1999-05-20 EP EP99920897A patent/EP1077687B1/fr not_active Expired - Lifetime
- 1999-05-20 BR BR9910606-0A patent/BR9910606A/pt not_active Application Discontinuation
- 1999-05-20 WO PCT/FR1999/001201 patent/WO1999059557A1/fr not_active Ceased
- 1999-05-20 CN CNB998074322A patent/CN1186014C/zh not_active Expired - Lifetime
- 1999-05-20 AT AT99920897T patent/ATE214598T1/de active
- 1999-05-20 PT PT99920897T patent/PT1077687E/pt unknown
- 1999-05-20 TR TR2001/00107T patent/TR200100107T2/xx unknown
- 1999-05-20 IL IL13977499A patent/IL139774A/xx not_active IP Right Cessation
- 1999-05-20 AU AU38302/99A patent/AU758299B2/en not_active Expired
- 1999-05-20 HU HU0102027A patent/HU224193B1/hu active IP Right Grant
- 1999-05-20 PL PL344314A patent/PL192950B1/pl unknown
-
2000
- 2000-11-17 NO NO20005838A patent/NO330501B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104963A patent/BG64764B1/bg unknown
- 2000-11-20 ZA ZA200006768A patent/ZA200006768B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ508392A (en) | Multiparticulate delayed release pharmaceutical form comprising at least two independent polymers with different permeability rates | |
| Milojevic et al. | Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets | |
| AU594392B2 (en) | Pharmaceutical preparation | |
| AU2256495A (en) | Sustained-release matrix pellets and method for preparing them | |
| AU1010500A (en) | Controlled Release Tramadol Preparations Having a Storage- stable Release Profile and Process for the Production Thereof | |
| CA2219698A1 (en) | Sustained-release preparation | |
| CA2191178A1 (en) | Long-lasting release nifedipine preparation | |
| LV12602A (en) | Enteric coated pharmaceutical composition and method of manufacturing | |
| HK43786A (en) | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration | |
| EP1030655A1 (en) | Low temperature coatings | |
| GB1593062A (en) | Coatings | |
| KR900011451A (ko) | 새로운 의약품 제제 | |
| CA2121038A1 (en) | Oral preparation for release in lower digestive tracts | |
| GB2359022A (en) | Controlled-release garlic formulations | |
| EP1722821A1 (en) | Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same | |
| DK1417960T3 (da) | Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf | |
| EP1095651A3 (en) | Multipor food protection | |
| NZ601969A (en) | Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane | |
| CA2651696A1 (en) | Modified release tablets comprising tramadol | |
| KR970032869A (ko) | 딜티아젬의 서방형 펠렛 제형 | |
| HK1029751B (en) | Process for the manufacture of a sustained release tramadol preparation with a storage stable release profile without curing of the coated product | |
| CA2298951A1 (en) | System and method for producing a pigmented cement composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| ASS | Change of ownership |
Owner name: ETHYPHARM, FR Free format text: OLD OWNER(S): LABORATOIRES PROGRAPHARM |
|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |